AMES Treatment of the Impaired Leg in Chronic Stroke Patients

PHASE1/PHASE2UnknownINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

January 31, 2011

Primary Completion Date

December 31, 2016

Study Completion Date

July 31, 2017

Conditions
StrokeCerebrovascular AccidentHemiparesis
Interventions
DEVICE

AMES- Leg treatment

30 minutes of treatment of the leg consisting of the AMES device passively moving the ankle between plantarflexion and dorsiflexion with vibration of the tendons being stretched, while the participant tries to assist in the movement as much as possible.

Trial Locations (2)

60611

Northwestern University/Rehabilitation Institute of Chicago, Chicago

97006

Oregon Health and Science University, Portland

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

Oregon Health and Science University

OTHER

collaborator

Northwestern University

OTHER

collaborator

Shirley Ryan AbilityLab

OTHER

collaborator

National Institute of Neurological Disorders and Stroke (NINDS)

NIH

lead

AMES Technology

INDUSTRY